Using the method of molecular genetic typing to determine variants of the weak antigen D in the diagnosis of Rh-affiliation

Abstract

Background. Determination of Rh-affiliation is mandatory for donors and recipients, surgical patients, pregnant women, etc. There are variants of the D antigen that are difficult to identify by serological methods, for example, a weak D antigen.

Aim. Determination of Rh-affiliation using genotyping in difficult cases, when the use of serological methods does not allow obtaining a reliable result.

Material and methods. We studied blood samples from donors (n=18), pregnant women (n=17) and patients with hematological diseases (n=15): 22 men and 28 women, median age 36 years (25 to 54 years). Serologically, antigen D was determined by gel technology in ID-cards and in an indirect antiglobulin test with anti-D-IgG reagent. Weak D antigen variants were diagnosed and phenotype determined using polymerase chain reaction with allele-specific primers. For significance of differences in the frequency of types of weak antigen D, a nonparametric statistical method using a two-tailed Fisher's exact test was used. Differences were considered statistically significant at p <0.05.

Results. The use of genotyping made it possible to detect the presence of a weak antigen D in 41 samples. Its specificity was represented by the following types: 1; 1.1; 2; 3. Other types of weak antigen D [4; 4.0; 4.1; 4.2 (DAR); 5; 11; 14; 15; 17] were absent. The study of the phenotype of erythrocyte antigens of the Rhesus system using genotyping revealed the predominance of the Ccee phenotype in people with a weak D antigen. Significant differences in the frequency of types of this antigen were revealed.

Conclusion. The use of molecular genetic typing made it possible to determine the types of the weak antigen D and to accurately determine the Rh-affiliation of the subjects.

Keywords

D antigen / D weak / D partial / phenotype / monoclonal antibodies / Rh-affiliation / serological methods / genotyping

References

[1] Flegel WA. Modern Rhesus (Rh) typing in transfusion and pregnancy. CMAJ. 2021;193(4):E124. DOI: 10.1503/cmaj.201212.

[2] Mineeva NV. Gruppy krovi cheloveka. Osnovy immunogematologii. (Human blood groups. Fundamentals of immunohematology.) Ed. 2nd, revised and supplemented. St. Petersburg: Gangut; 2020. 360 p. (In Russ.)

[3] Минеева Н.В. Группы крови человека. Основы иммуногематологии. Изд. 2-е, переработанное и дополненное. СПб.: Гангут; 2020. 360 с.

[4] Golovkina LL, Kalandarov RS, Pshenichnikova OS, Surin VL, Stremou-khova AG, Pushkina TD, Khasigova BB. Identification of common and new rare types of weak RHD antigen in patients with diseases of the blood system and healthy individuals. Oncohematology. 2019;14(3):52–59. (In Russ.) DOI: 10.17650/1818-8346-2019-14-3-52-59.

[5] Головкина Л.Л., Каландаров Р.С., Пшеничникова О.С., Сурин В.Л., Стремоухова А.Г., Пушкина Т.Д., Хасигова Б.Б. Выявление распространённых и новых редких типов слабого антигена RHD у больных с заболеваниями системы крови и здоровых лиц. Онкогематология. 2019;14(3):52–59. DOI: 10.17650/1818-8346-2019-14-3-52-59.

[6] Wagner FF, Frohmajer А, Ladewig В, Eicher NI, Lonicer CB, Müller TH, Siegel MH, Flegel WA. Weak D alleles express distinct phenotypes. Blood. 2000;95(8):2699–2708. DOI: 10.1182/blood.V95.8.2699.008k12_2699_2708.

[7] Flegel WA, Zabern IV, Wagner FF. Six years’ experience performing RHD genotyping to confirm D− red blood cell units in Germany for preventing anti-D immunizations. Transfusion. 2009;49:465–471. DOI: 10.1111/j.1537-2995.2008.01975.x.

[8] Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: A review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol. 2017;179(1):10–19. DOI: 10.1111/bjh.14757.

[9] Garratty G. Do we need to be more concerned about weak D antigens? Transfusion. 2005;45:1547–1551. DOI: 10.1111/j.1537-2995.2005.00625.x

[10] Vege S, Sprogøe U, Lomas-Francis С, Jakobsen M, Antonsen B, Aeschlimann J, Yazer M, Westhoff CM. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles. Transfusion. 2021;61:256–265. DOI: 10.1111/trf.16100.

[11] Perez-Alvarez I, Hayes C, Tiruneh Hailemariam T, Shin E, Hutchinson T, Klapper E. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center. Transfusion. 2019;59(7):2422–2428. DOI: 10.1111/trf.15325.

[12] Sandler SG, Horn T, Keller J, Langeberdg A, Keller MA. A model for integrating molecular-based testing in a transfusion service. Blood Transfus. 2016;14(6):566–572. DOI: 10.2450/2015.0070-15.

[13] Mineyeva NV, Yelkhina EV, Bodrova NN, Zavarzina OA, Priyezzheva LS, Poyedinenko IV. D antigen varieties and determination of rhesus factor. Klinicheskaya laboratornaya diagnostika. 2009;(3):19–21. (In Russ.)

[14] Минеева Н.В., Елхина Е.В., Бодрова Н.Н., Заварзина О.А., Приезжева Л.С., Поединенко И.В. Разновидности антигена D и определение резус-принадлежности крови. Клиническая лабораторная диагностика. 2009;(3):19–21. EDN: KHPHOB.

[15] Golovkina LL, Stremoukhova AG, Pushkina TD, Kalandarov RS, Atroshchenko GV, Vasilyeva MN, Surin VL, Salomashkina VV, Pshenichnikova OS, Miterev GYu, Parovichnikova EN, Savchenko VG. Molecular serological characteristics of weak D antigen types of the Rhesus system. Terapevticheskii Arkhiv. 2016;88(7):78–83. (In Russ.) DOI: 10.17116/terarkh201688778-83.

[16] Головкина Л.Л., Стремоухова А.Г., Пушкина Т.Д., Каландаров Р.С., Атрощенко Г.В., Васильева М.Н., Сурин В.Л., Саломашкина В.В., Пшеничникова О.С., Митерев Г.Ю., Паровичникова Е.Н., Савченко В.Г. Молекулярно-серологические характеристики типов слабого антигена D системы резус. Терапевтический архив. 2016;88(7):78–83. DOI: 10.17116/terarkh201688778-83.

[17] Lamzin IM, Sokolova MN, Khairullin RM, Mineeva NV, Hapman ME. Features of immunohematological and hematological parameters of a donor with a rare phenotype -D-. Russian journal of hematology and transfusiology. 2020;65(1):52–60. (In Russ.) DOI: 10.35754/02345730-2020-65-1-52-60.

[18] Ламзин И.М., Соколова М.Н., Хайруллин Р.М., Минеева Н.В., Хапман М.Э. Особенности иммуногематологических и гематологических показателей крови донора с редким фенотипом -D-. Гематология и трансфузиология. 2020;65(1):52–60. DOI: 10.35754/02345730-2020-65-1-52-60.

[19] Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Johnson ST, Katz L, Queenan JT, Vassallo RR, Simon CD. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion. 2015;55:680–689. DOI: 10.1111/trf.12941.

[20] Sapatnekar S, Figueroa PI. How do we use molecular red blood cell antigen typing to supplement pre transfusion testing? Transfusion. 2014;54:1452–1458. DOI: 10.1111/trf.12623.

[21] Chen LN, Fliegel WA. Serological phenotypes of weak D: A review and guide to the interpretation of the RhD blood group using the RHD genotype. Br J Haematol. 2017;179(1):10–19. DOI: 10.1111/bjh.14757.

RIGHTS & PERMISSIONS

Eco-Vector